芦康沙妥珠单抗治疗EGFR-TKIs进展后的非鳞NSCLC的成本-效用分析
蒋媛, 王美飒, 高靓, 高宇阳, 杨凤昆
Cost-utility analysis of sacituzumab tirumotecan in non-squamous NSCLC after progression on EGFR-TKIs
JIANG Yuan, WANG Meisa, GAO Liang, GAO Yuyang, YANG Fengkun
中国医院药学杂志
.
2026, (16): 1877
-1883
.
DOI: 10.13286/j.1001-5213.2026.16.06
